AusPAR: Comirnaty

Australian Public Assessment Report

AusPAR

AusPAR: Comirnaty [PDF, 1.62 MB]

AusPAR: Comirnaty [Word, 2.3 MB]

AusPAR Attachment 1: Product Information for Comirnaty [PDF, 868.3 KB]

AusPAR Attachment 1: Product Information for Comirnaty [Word, 2.53 MB]

Device/Product Name

Comirnaty

Active ingredients

Tozinameran (formerly BNT162b2 [mRNA])

AusPAR Date

30 September 2022

Published

10 October 2022

Submission Number

PM-2022-02476-1-2

Submission Type

Major variation

Decision

Approved